Metraipolis › archive › dc_ecf64b44ac8e

Real-world evidence for the postmarket surveillance of cancer medicines: opportunities and challenges using Australia's population-based cancer registries — Europe PMC PMID:42542683

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42542683
DOI
10.1016/j.esmorw.2026.100748
License (as archived)
solo-consultazione
Archived
2026-10-07T15:16:23.929Z
SHA-256 of the archived text
a84910e15a6dab9d5de937fbf8ce34df218f21917f7c34740b2d3f0d219c7508
Stable URL of this page
https://metraipolis.com/documento/dc_ecf64b44ac8e

How to cite

Real-world evidence for the postmarket surveillance of cancer medicines: opportunities and challenges using Australia's population-based cancer registries — Europe PMC PMID:42542683 — Europe PMC (en), https://europepmc.org/article/MED/42542683 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ecf64b44ac8e (Metraipolis archive dc_ecf64b44ac8e, sha256 a84910e15a6dab9d5de937fbf8ce34df218f21917f7c34740b2d3f0d219c7508)
BibTeX
@misc{dcecf64b44ac8e,
  title = {Real-world evidence for the postmarket surveillance of cancer medicines: opportunities and challenges using Australia's population-based cancer registries — Europe PMC PMID:42542683},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42542683},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ecf64b44ac8e; sha256 a84910e15a6dab9d5de937fbf8ce34df218f21917f7c34740b2d3f0d219c7508},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42542683. Agents can read the archived copy with the MCP tool read_document.